How MGI Helps Uncover the Mystery of HIV Elite Controllers with Genomics Technology: A South African Case Study

MGI Tech Co., Ltd. South Africa

on its portable low throughput DNBSEQ-E25, and mid-low throughput DNBSEQ-G99 sequencers. This package unitizes deep sequencing to detect low-frequency mutation associated with drug resistance. When combined with MGI's automated sample preparation systems and HIV-Genome Pro software, users benefit from a streamlined tool capable of rapid and accurate detection of HIV-1, drug resistance analysis, genome assembly, mutation detection, and evolutionary tracing.

The process is highly efficient with DNBSEQ-E25 to process up to 16 samples from RNA to report in 28.5 hours, while DNBSEQ-G99 can handle up to 120 samples in just 24 hours.

For more details on this groundbreaking HIV research project, check out this in-depth video created in collaboration with Nature Research Custom Media.

Photo - https://mma.prnewswire.com/media/2463430/1.jpg
Logo - https://mma.prnewswire.com/media/2329841/MGI__Logo.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/how-mgi-helps-uncover-the-mystery-of-hiv-elite-controllers-with-genomics-technology-a-south-african-case-study-302199413.html